sirolimus and Alveolitis--Extrinsic-Allergic

sirolimus has been researched along with Alveolitis--Extrinsic-Allergic* in 3 studies

Other Studies

3 other study(ies) available for sirolimus and Alveolitis--Extrinsic-Allergic

ArticleYear
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report.
    BMC research notes, 2013, Nov-18, Volume: 6

    Novel therapeutic agents are currently being investigated for neuroendocrine tumour treatment.. We report here on the case of a patient presenting with hypersensitivity pneumonitis while being treated with everolimus, a mammalian target of rapamycin (mTOR) inhibitor.. Side effects of everolimus should be familiar to clinicians, including nonspecialists, and be monitored carefully to allow for prompt management.

    Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Everolimus; Humans; Intestine, Small; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Sirolimus

2013
Zotarolimus-eluting stent-induced hypersensitivity pneumonitis.
    The Korean journal of internal medicine, 2013, Volume: 28, Issue:1

    Topics: Alveolitis, Extrinsic Allergic; Biopsy; Drug Hypersensitivity; Drug-Eluting Stents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Sirolimus; Steroids; Tomography, X-Ray Computed; Treatment Outcome

2013
Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate.
    Chest, 2006, Volume: 129, Issue:6

    The differential diagnosis of pulmonary infiltrates after solid-organ transplantation presents a broad differential diagnosis including opportunistic infections and drug-induced lung disease. We report an adult liver transplant recipient who had breathlessness and pulmonary infiltrates following the introduction of sirolimus, and in whom transbronchial biopsy demonstrated a granulomatous interstitial pneumonitis and an organizing pneumonia with a CD4 T-cell infiltrate suggesting a T-helper cell-associated reaction to a processed sirolimus protein complex. Withdrawal of sirolimus produced a rapid clinical and radiologic improvement. This case indicates that with the increasing use of sirolimus, clinicians need to be aware of pulmonary hypersensitivity from this agent.

    Topics: Aged; Alveolitis, Extrinsic Allergic; CD4-Positive T-Lymphocytes; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Pneumonia; Sirolimus

2006